Successful Treatment of Behcet's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation

  • Nakamura Yukinori
    Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan
  • Matsuguma Masafumi
    Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan
  • Tokunaga Yoshihiro
    Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan
  • Yamamoto Kaoru
    Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan
  • Tanaka Mayumi
    Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan
  • Tanaka Yoshinori
    Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan
  • Yujiri Toshiaki
    Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan
  • Tanizawa Yukio
    Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan

書誌事項

タイトル別名
  • Successful Treatment of Behçet's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation

この論文をさがす

説明

<p>The coexistence of acute myeloid leukemia (AML) with Behçet's disease (BD) is rare. The optimum treatment for AML-associated BD has not been established. We herein report a patient with BD who developed AML with myelodysplasia-related changes. Induction chemotherapy caused complete remission of the AML but worsened the BD. Thereafter, AML was treated with azacitidine. The BD was steroid-dependent. Tacrolimus was added, which improved the BD. The patient underwent allogeneic hematopoietic stem cell transplantation (HSCT) and remains in complete remission for both diseases. Allogeneic HSCT was found to be a potent therapeutic option for AML-associated BD. In addition, azacitidine and tacrolimus were shown to be a suitable bridging regimen before HSCT. </p>

収録刊行物

  • Internal Medicine

    Internal Medicine 56 (10), 1199-1202, 2017

    一般社団法人 日本内科学会

被引用文献 (2)*注記

もっと見る

参考文献 (13)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ